Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Viral hepatitis C is treated with peg-interferon alpha 2a/2b and ribavirin. There is no
treatment recommended for non responders patients. This study will evaluate the efficacy,
after a second treatment with peg-interferon alpha 2a and ribavirin for 12 Weeks of the
addition of interferon gamma in non responders patients
Phase:
Phase 2
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis